Consumer Health Data Privacy Policy

STAAR SURGICAL CONSUMER HEALTH DATA PRIVACY POLICY

Last Updated: October 30, 2026

INTRODUCTION

STAAR Surgical Company and our global subsidiaries and affiliates (collectively, “STAAR,” “we,” “us,” and “our”) are committed to respecting your privacy. This Consumer Health Data Privacy Policy supplements the STAAR Surgical Privacy Policy and applies to personal data defined as “consumer health data” subject to the Washington State My Health My Data Act. 

CONSUMER HEALTH DATA COLLECTED

Consumer health data means personal information that is linked or reasonably linkable to a consumer and that identifies the consumer’s past, present, or future physical or mental health status. The consumer health data we collect depends on the context of your interaction with us. Examples of consumer health data we may collect in the course of providing our services include information about an individual’s:

  • health conditions, treatment, diseases, or diagnoses (e.g., vision disorders);
  • medical interventions;
  • use or purchase of medications or prescribed medications;
  • measurements of health information (e.g., eye measurements);
  • diagnoses or diagnostic testing, treatment, or medication; or
  • information that could identify an individual seeking health care services or information. 

SOURCES OF CONSUMER HEALTH DATA

We collect consumer health data from the following sources:

  • directly from you when you interact with us or use our services;
  • automatically through cookies and other tracking technologies that reveal your interest in our services; or
  • from third parties such as healthcare providers who provide health data to us pursuant to your authorization.

PURPOSES FOR COLLECTION AND USE

Our collection of consumer health data is necessary for the provision of our services. In addition, we may use consumer health data to compile analytics, improve our services, comply with legal and regulatory obligations, for any other purpose with your consent, or otherwise as described in the STAAR Surgical Privacy Policy.

DISCLOSURE OF CONSUMER HEALTH DATA

In addition to sharing consumer health data with our service providers, we may share consumer health data with the following third parties:

  • Our affiliates listed in Annex I below.
  • Certain third parties with your consent or at your direction. These parties may include healthcare providers.
  • Other third parties to protect our rights, defend or pursue a legal claim, or investigate or prosecute illegal activities.
  • Government or judicial authorities or agencies to comply with a subpoena, court order, governmental inquiry, legal process, legal obligation, or to protect the rights, property, or safety of other users or the public, including mandatory disclosures to public health authorities or adverse event reporting to regulatory agencies.

We may also share consumer health data with a successor entity or purchaser upon a merger, consolidation, or other corporate reorganization in which we participate, or pursuant to a financing arrangement. 

YOUR RIGHTS

Washington residents have the following rights with respect to their consumer health data, subject to certain exceptions:

  • the right to confirm whether we process your consumer health data, and to access and receive a copy of your consumer health data;
  • the right to a list of all third parties and affiliates with whom we have shared or sold your consumer health data and an email address or other online mechanism that you can use to contact each third party;
  • the right to delete your consumer health data; and
  • the right to withdraw consent to the collection, sharing, or selling of consumer health data.

You can submit a request to exercise these rights using any of the mechanisms listed in the “Contact Information” section below. Depending on the type of request, we may need to verify your request before we can fulfill it. Please note that certain exceptions may apply to these rights (e.g., we may be unable to honor a request to delete if it conflicts with a legal obligation to retain data). Finally, please review the STAAR Surgical Privacy Policy for additional rights and choices you may have with respect to your personal data more generally.

You have the right to appeal any decisions we make in response to a rights request. If your appeal is unsuccessful, you can raise a concern or lodge a complaint with the Washington State Attorney General at www.atg.wa.gov/file-complaint.

 

CHANGES TO THIS POLICY

We may revise this policy from time to time. When we make changes to this policy, we will post the updated version on our website and indicate the date the policy was last updated. We encourage you to review this policy periodically to check for any updates.

CONTACT INFORMATION

If you have questions or concerns regarding this policy or wish to exercise your privacy rights, please contact us at:

STAAR Surgical Company

25510 Commercentre Drive, Ste. 200, Lake Forest, California 92630, USA

Phone: 1.626.303.7902

Email: PrivacyOffice@staar.com

SUPPLEMENT TO CONSUMER HEALTH DATA PRIVACY POLICY FOR NEVADA CONSUMERS

This supplement to our Consumer Health Data Privacy Policy applies to Nevada residents for purposes of providing additional disclosures required by Nevada’s consumer health data privacy law (Nevada Senate Bill 370).

The foregoing consumer health data disclosures and rights also apply to Nevada residents. In addition, Nevada residents also have the right to review and amend any consumer health data we maintain about them. Nevada residents can escalate unsuccessful appeals of consumer rights requests to the Nevada attorney general at https://ag.nv.gov/Complaints/CSU_Complaints___FAQ/. Third parties may collect consumer health data over time and across different websites when you use our websites.

ANNEX I: LIST OF RELEVANT STAAR ENTITIES

  1. STAAR Surgical Company (Delaware, United States)
  2. STAAR Surgical AG (Nidau, Switzerland)

Wichtige Sicherheitsinformationen

Die ICL ist für die Korrektur/Reduzierung von Kurzsichtigkeit bei Patienten im Alter von 21 bis 60 Jahren im Bereich von -0,5 D bis -20,0 D mit oder ohne Astigmatismus bis zu 6 D und für die Korrektur/Reduzierung von Weitsichtigkeit bei Patienten im Alter von 21 bis 45 Jahren mit einer Weitsichtigkeit im Bereich von +0. 5 D bis +16,0 D mit oder ohne Astigmatismus bis zu 6 D. Um sicher zu sein, dass Ihr Chirurg eine ICL mit der für Ihr Auge am besten geeigneten Stärke einsetzt, sollten Ihre Kurzsichtigkeit, Weitsichtigkeit und Ihr Astigmatismus mindestens ein Jahr lang stabil sein, bevor Sie sich einer Augenoperation unterziehen. Eine ICL-Operation kann Ihre Sehkraft ohne Brille oder Kontaktlinsen verbessern. Die ICL-Operation macht eine Lesebrille nicht überflüssig, selbst wenn Sie sie vorher nie getragen haben. Die ICL-Operation ist eine Alternative zu anderen refraktiven Eingriffen wie der laserunterstützten In-situ-Keratomileusis (LASIK), der photorefraktiven Keratektomie (PRK), und weiteren Korrekturen mittels Schnitt-Techniken oder anderen Mitteln zur Korrektur Ihrer Sehkraft wie Kontaktlinsen und Brillen. Die Implantation einer ICL ist ein chirurgischer Eingriff und birgt als solcher potenziell ernsthafte Risiken. Die folgenden potenziellen Komplikationen/Nebenwirkungen wurden im Zusammenhang mit refraktiven Eingriffen im Allgemeinen berichtet: zusätzliche Operationen, Kataraktbildung, Verlust des bestkorrigierten Sehvermögens, erhöhter Druck im Inneren des Auges, Verlust von Zellen auf der innersten Oberfläche der Hornhaut, Bindehautreizung, akute Hornhautschwellung, anhaltende Hornhautschwellung, Endophthalmitis (totale Augeninfektion), signifikante Blendung und/oder Lichthöfe um Lichter herum, Hyphaem (Blut im Auge), Hypopyon (Eiter im Auge), Augeninfektion, ICL-Verschiebung, Makulaödem, nicht reaktionsfähige Pupille, Pupillenblockglaukom, schwere Entzündung des Auges, Iritis, Uveitis, Glaskörperverlust und Hornhauttransplantation. Bevor Sie eine ICL-Operation in Erwägung ziehen, sollten Sie eine vollständige Augenuntersuchung durchführen lassen und mit Ihrem Augenarzt über die ICL-Operation sprechen, insbesondere über die möglichen Vorteile, Risiken und Komplikationen. Sie sollten auch über die Zeit sprechen, die für die Heilung nach der Operation benötigt wird.

Referenzen

Referenzen

1. Patient Survey, STAAR Surgical ICL Data Registry, 2018

2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018

3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council